首药控股10月13日获融资买入326.51万元，融资余额2.87亿元

Group 1 - The core viewpoint of the news is that Shouyao Holdings experienced a decline in stock price and trading volume, indicating potential liquidity issues and investor sentiment concerns [1] - On October 13, Shouyao Holdings' stock price fell by 2.86%, with a trading volume of 43.49 million yuan, and a net financing buy of -48,200 yuan [1] - As of October 13, the total margin balance for Shouyao Holdings was 287 million yuan, accounting for 11.04% of its market capitalization, which is above the 80th percentile of the past year [1] Group 2 - As of June 30, the number of shareholders for Shouyao Holdings increased by 5.33% to 4,526, while the average circulating shares per person decreased by 5.06% to 14,141 shares [2] - For the first half of 2025, Shouyao Holdings reported a revenue of 2 million yuan, a year-on-year decrease of 47.37%, and a net profit attributable to shareholders of -104 million yuan, a decrease of 1.48% year-on-year [2] - Among institutional holdings, as of June 30, 2025, Penghua Medical Technology Stock A was the largest shareholder with 5.41 million shares, unchanged from the previous period, while China Europe Medical Health Mixed A entered as the tenth largest shareholder with 1.17 million shares [2]